C40H55N5O5 — CID 123321951
[(11S,13S)-11-[4-[2-[4-[[(1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yl)amino]methyl]-4,5-dihydrotriazol-1-yl]ethoxy]phenyl]-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] acetate (PubChem CID 123321951) has the molecular formula C40H55N5O5 and a molecular weight of 685.91 g/mol. Its IUPAC name is [(11S,13S)-11-[4-[2-[4-[[(1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yl)amino]methyl]-4,5-dihydrotriazol-1-yl]ethoxy]phenyl]-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] acetate.
| Compound Name | [(11S,13S)-11-[4-[2-[4-[[(1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yl)amino]methyl]-4,5-dihydrotriazol-1-yl]ethoxy]phenyl]-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] acetate |
|---|---|
| PubChem CID | 123321951 |
| Molecular Formula | C40H55N5O5 |
| Molecular Weight | 685.91 g/mol |
| Exact Mass | 685.42 |
| IUPAC Name | [(11S,13S)-11-[4-[2-[4-[[(1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yl)amino]methyl]-4,5-dihydrotriazol-1-yl]ethoxy]phenyl]-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] acetate |
| SMILES | CC(=O)Oc1ccc2c(c1)CCC1C2[C@@H](c2ccc(OCCN3CC(CNC4CC(C)(C)N(O)C(C)(C)C4)N=N3)cc2)C[C@]2(C)C(=O)CCC12 |
| InChI | InChI=1S/C40H55N5O5/c1-25(46)50-31-12-14-32-27(19-31)9-13-33-35-15-16-36(47)40(35,6)22-34(37(32)33)26-7-10-30(11-8-26)49-18-17-44-24-29(42-43-44)23-41-28-20-38(2,3)45(48)39(4,5)21-28/h7-8,10-12,14,19,28-29,33-35,37,41,48H,9,13,15-18,20-24H2,1-6H3/t29?,33?,34-,35?,37?,40+/m1/s1 |
| InChIKey | LHOZLLDEQYUKIL-JRJGHCPUSA-N |
| XLogP | 6.86 |
| TPSA | 116.06 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 50 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 685.91 |
| LogP ≤ 5 | 6.86 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
| Structural Alerts | {'alert_name': 'phenol_ester', 'substructure': 'N/A'} |
|---|